ArticleNeurosciences (Riyadh, Saudi Arabia)2026
Association Between Extracranial Artery Stenosis and Cerebral Small-Vessel Disease in Patients with Ischemic Stroke.
Article in Neurosciences (Riyadh, Saudi Arabia), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To review the relationship between extracranial artery stenosis (ECAS) severity and total cerebral small-vessel disease (CSVD) burden and evaluated 5-year mortality, disability, and stroke recurrence in ischemic stroke patients. Cerebral small-vessel disease and ECAS often share risk factors such as hypertension and atherosclerosis and coexist in ischemic stroke. Although ECAS affects large-artery disease, its impact on total CSVD burden on MRI and subsequent clinical outcomes is not well defined. Methods: We retrospectively reviewed the medical records of 348 patients older than 35 who had suffered acute ischemic stroke and were admitted to selected hospitals in Tehran, Iran from March 2018-March 2020. The patients were stratified into 4 ECAS groups, and brain MRIs were scored to yield a total CSVD burden score. Ordinal logistic regression was used to examine the association between ECAS category and CSVD score, adjusting for age, sex, hypertension, diabetes mellitus, and hyperlipidemia. Logistic regression assessed 5-year outcomes. Results: Of the 309 patients with complete imaging, increasing ECAS severity was independently associated with a higher CSVD burden (adjusted OR 1.86; 95% CI 1.56-2.22; p<0.001). Five-year mortality was 39.9%, and severe ECAS predicted lower survival rates (adjusted OR 2.43; 95% CI 1.02-5.78; p = 0.045). However, ECAS was not linked to disability (p = 0.077) or recurrence (p = 0.191). Conclusions: We found that ECAS severity correlated with greater CSVD burden and poorer long-term survival in ischemic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.